✦ LIBER ✦

A Phase II Study of Estramustine, Docetaxel, and Exisulind in Patients with Hormone- Refractory Prostate Cancer: Results of Cancer and Leukemia Group B Trial 90004

✍ Scribed by Nancy A. Dawson; Susan Halabi; San-San Ou; David D. Biggs; Anne Kessinger; Nicholas Vogelzang; Gerald H. Clamon; David M. Nanus; W. Kevin Kelly; Eric J. Small

Book ID: 115075970
Publisher: CIG Media Group, LP.
Year: 2008
Tongue: English
Weight: 130 KB
Volume: 6
Category: Article
ISSN: 1558-7673
DOI: 10.3816/cgc.2008.n.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase-II Study of Docetaxel, Estramustin

Phase-II Study of Docetaxel, Estramustine Phosphate, and Carboplatin in Patients with Hormone-Refractory Prostate Cancer

✍ Nobuyuki Kikuno; Shinji Urakami; Shigeru Nakamura; Takeo Hiraoka; Taijyu Hyuga; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 176 KB

A Phase I Trial of Docetaxel/Estramustin

A Phase I Trial of Docetaxel/Estramustine/Imatinib in Patients with Hormone-Refractory Prostate Cancer

✍ Amy M. Lin; Brian I. Rini; Mika K. Derynck; Vivian Weinberg; Margaret Park; Char 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 117 KB

A phase I/II dose-escalation study of ex

A phase I/II dose-escalation study of exisulind and docetaxel in patients with hormone-refractory prostate cancer

✍ Christopher W. Ryan; Walter M. Stadler; Nicholas J. Vogelzang 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

A phase II trial of docetaxel and vinore

A phase II trial of docetaxel and vinorelbine in patients with hormone-refractory prostate cancer

✍ Susan Goodin; Kamakshi V. Rao; Michael Kane; Nisha Dave; Terry Capanna; Susan Do 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 200 KB

Results from a pilot Phase I trial of ge

Results from a pilot Phase I trial of gefitinib combined with docetaxel and estramustine in patients with hormone-refractory prostate cancer

✍ George Wilding; Patrick Soulie; Donald Trump; Ashis Das-Gupta; Eric Small 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

A Phase II study of estramustine, doceta

A Phase II study of estramustine, docetaxel, and carboplatin with granulocyte–colony-stimulating factor support in patients with hormone-refractory prostate carcinoma : Cancer and Leukemia Group B 99813

✍ William K. Oh; Susan Halabi; W. Kevin Kelly; Cary Werner; Paul A. Godley; Nichol 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 2 views

## Abstract ## BACKGROUND The authors determined the safety and efficacy of estramustine, docetaxel, and carboplatin with granulocyte–colony‐stimulating factor (G‐CSF) support in patients with hormone‐refractory prostate carcinoma. ## METHODS In the current multicenter, cooperative group study,